Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-14 · accession 0001127602-24-010517 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-18 | 2024-03-14 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +16.9K | 63.9K | +36% | $0 |
| DM | 2024-03-18 | 2024-03-14 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +19.6K | 1,224 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-14 | A | A | 16,941 | $0.00 | 63,887 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-03-14 | A | A | 18,346 | $0.00 | 18,346 | D | $63.75 · 2024-04-15 to 2034-03-14 | 18,346 Common Stock | |
| 3 | Derivative | Incentive Stock Option (Right to Buy) | 2024-03-14 | A | A | 1,224 | $0.00 | 1,224 | D | $63.75 · 2024-04-15 to 2034-03-14 | 1,224 Common Stock |